Plain-English translation of NCT05712746 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This is a safety monitoring study of tolvaptan sodium phosphate, a medication designed to help remove excess fluid from the body in people with heart failure. Researchers are collecting real-world information about how well this treatment works and whether it is safe when used in everyday medical practice. The study involves about 1,600 patients.
Even after a medication is approved and available to patients, doctors and drugmakers need to keep watching how it performs and whether any new safety concerns come up. This study was created to gather that ongoing safety information as this medication is used by many different patients in real medical settings.
This is a monitoring study rather than a traditional research trial—it watches how patients do when they take this medication as part of their normal care. You would take the medication as prescribed by your doctor, and researchers would collect information about your safety and how the treatment is working. The study is currently active but not enrolling new participants at this time.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Japan